Digital Health in Asia

Afterall, according to a recent research by PwC, 60% of Singaporeans own a wearable device which include fitness bands, smart watches, smart glasses and even smart clothing. These devices, and many more like them, broadly fall within category of wearables that we see in the market today. Wearable health digital devices and related Web 2.0 apps coupled with social media tools have brought about new and revolutionary ways of monitoring, measuring and representing the human body – ‘The Quantified Self’.

The question is – are these part of the latest consumer trend or is there a broader implication of this trend within the healthcare industry?

Find out more by clicking here to read the full article.

In conjunction with this, Real Life Sciences will be holding a networking session alongside a panellist discussion on "Digital Healthcare in Asia". Our panellist consist of Strategy and Digital Healthcare Strategists from leading pharmaceutical companies in the region. If you’re interested to find out more, please contact Samarth Goel at [email protected]  or Lausanne Lau at [email protected]

 

Real Life Sciences will attend DIA 2019

01 Nov 2019

Real Life Sciences will be partnering with DIA (Drug Information Association) Japan’s Annual Meeting this year again. We have established a strong partnership with DIA around the world, including Europe, the United States, and Singapore, and we are pleased to be a part of a leading community of professionals within the life science industry.

Tags: DIA PHARMA

Can Korea’s medical affairs teams overcome barriers to success?

01 May 2019

Find out if Korea’s medical affairs teams are able to overcome barriers to success?

Real Life Sciences Singapore expands to Hong Kong

01 Apr 2019

Read more about Real Life Sciences in Hong Kong

How will global trends shake up South Korea’s medical scene?

01 Mar 2019

Read about how global trends shake up South Korea’s medical scene?